CARL — CARLSMED INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying CARL?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their CARL position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +1 tracked investor added or increased positions last quarter (Steve Cohen)
- +3 tracked investors reported holding CARL at their latest filing
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About CARLSMED INC (CARL)
CARLSMED INC (CARL) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $7M. Across recent filings, tracked investors recorded 2 new positions, 1 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CARL
How many top investors track CARL
A small number of top investors own this.
CARL Ownership Composition
How CARLSMED INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting CARL
- Steve CohenSep 30, 2026Point72 Asset ManagementShares495.8KValue$7M% Portfolio0.01%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares60.6KValue$852.9K% Portfolio0.00%
- Ken GriffinSep 30, 2026Citadel AdvisorsShares67.7KValue$952.6K% Portfolio0.00%
Recent activity
- Reduced$852.9K(-79.51%)Nov 16, 2026
- New$7MNov 16, 2026
- Increased$1.6M(521.18%)Feb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- $3.1MAug 14, 2026
Frequently asked questions
- How many institutional investors hold CARL?
- 3 tracked institutional investors disclosed a position in CARL (CARLSMED INC) in their most recent 13F filing.
- Who is the largest institutional holder of CARL?
- Steve Cohen, Point72 Asset Management, holds the largest disclosed position in CARL, valued at $7M.
- Did institutional ownership of CARL increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 1 increased, 1 reduced, and 1 fully exited CARL.
- Where does this CARL ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.